Scholay

学术搜索 · AI 审稿 · LaTeX 协作

916O Preliminary phase I results of INCB161734, a novel oral KRAS G12D inhibitor, in patients with advanced or metastatic solid tumors

作者:J. Desai, B. Markman, M. Millward, E. Garralda, Z.A.A. Wainberg, Martin Gutierrez, James A. Henry, H. Park, Rasha Cosman, Antoine Hollebecque, M.J. Borad, Ali McBride, Linda Favre-Kontula, Ming Zhou, Aidan G. Gilmartin, X. Gong, M. Hidalgo · 发表于:Annals of Oncology · 年份:2025 · DOI:10.1016/j.annonc.2025.08.1485 · 被引用次数:10 · 研究领域:Protein Kinase Regulation and GTPase Signaling、Colorectal Cancer Treatments and Studies、HER2/EGFR in Cancer Research